Coury, Jennifer http://orcid.org/0000-0002-3597-9517
Miech, Edward J.
Styer, Patricia
Petrik, Amanda F.
Coates, Kelly E.
Green, Beverly B.
Baldwin, Laura-Mae
Shapiro, Jean A.
Coronado, Gloria D.
Funding for this research was provided by:
Centers for Disease Control and Prevention (U48DP005013)
Article History
Received: 2 June 2020
Accepted: 15 December 2020
First Online: 11 January 2021
Ethics approval and consent to participate
: All study documents were reviewed and approved by the University of Washington Institutional Review Board (Protocol number: 00000472); a waiver of informed consent was obtained given minimal risks imposed to study participants.
: There are no individual person’s data provided in any form.
: From September 2017 to June 2018, Kaiser Permanente Center for Health Research (Dr. Coronado served as the Principal Investigator) participated in an industry-funded study to compare the clinical performance of an experimental fecal immunochemical test (FIT) to an FDA-approved FIT. This study was funded by Quidel Corporation. From February 2016 to July 2018, Jennifer Coury was contracted with CareOregon, Inc., to improve colorectal cancer screening rates in health plan members, including coordination of a mailed FIT program. All other authors declare no competing interests.